ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "risk assessment"

  • Abstract Number: 0759 • ACR Convergence 2020

    Presence of Ultrasound Imaging Biomarkers Are Good Predictors of Arthritis Development in a Population at Risk for Rheumatoid Arthritis

    Yogan Kisten1, Alexandra Circiumaru1, Malena Loberg-Haarhaus2, Nancy Vivar2, Aleksandra Antovic3, Hamed Rezaei2, Erik Af Klint1, Aase Hensvold1 and Anca Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 2Rheumatology clinic, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 3Center for Rheumatology, Academic Specialist Center, Stockholm Health Region, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden

    Background/Purpose: Ultrasound (US) imaging biomarkers in the context of Anti-Citrullinated Protein Antibody (ACPA) autoimmunity might play an important role in the very early detection of…
  • Abstract Number: 1006 • ACR Convergence 2020

    Post-menopausal Rheumatoid Arthritis Is Inversely Associated with Lifetime High Level of Estrogen Exposure in the French E3N Cohort

    Carine Salliot1, Yann Nguyen2, Amandine Gelot3, Xavier Mariette4, Marie-Christine Boutron-Ruault3 and Raphaèle Seror5, 1CHR orleans, Orleans, France, 21Department of Internal Medicine, Hôpital Beaujon, APHP Nord, Université de Paris, Clichy, Clichy, France, 3Institut Gustave Roussy, Villejuif, France, 4Paris-Sud University, Rueil-Malmaison, France, 5Rheumatology Department, Bicetre Hospital, APHP, France, Paris, France

    Background/Purpose: The involvement of female hormones in the pathogenesis of Rheumatoid Arthritis (RA) is supported by numerous observations: a female predominance, an increased incidence in…
  • Abstract Number: 1021 • ACR Convergence 2020

    Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status

    Romy Kallas1, Jessica Li2, Daniel Goldman3 and Michelle Petri3, 1Johns Hopkins Medical Institution, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: Multiple variables are known to contribute to development of organ damage in SLE patients, including prednisone use and ethnicity. The aim of this study…
  • Abstract Number: 1066 • ACR Convergence 2020

    Prevalence of Cervical Dysplasia in Women with Antisynthetase Syndrome

    Alexis Katz1, Yuxuan Jin1 and Soumya Chatterjee2, 1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Richmond Heights, OH

    Background/Purpose: Increased risk of cervical dysplasia and cervical cancer have been reported in patients with systemic lupus erythematosus (SLE). However, the reason for this increased…
  • Abstract Number: 1149 • ACR Convergence 2020

    Risk Score of Macrophage Activation Syndrome (MAS) in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA)

    Simone Carbogno1, Denise Pires Marafon2, Giulia Marucci2, Emanuela Sacco2, Manuela Pardeo2, Alhanouf Alsaleem3, Sarka Fingerhutova4, Ferhat Demir5, Nastasia Cekada6, Mikhail Kostik7, Christoph Kessel8, Olga Vougiouka9, Alenka Gagro10, Jessica Tibaldi11, Francesca Minoia12, Ilaria Maccora13, Rayfel Schneider14, Pavla Dolezalova15, Betul Sozeri16, Marija Jelusic6, Antonella Insalaco2, Fabrizio De Benedetti17 and Claudia Bracaglia2, 1Pediatric Area, University of Milan, Milan, Italy, 2Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 3Division of Pediatric Rheumatology, Department of pediatrics, King Faisal specialist hospital and research center, Riyadh, Saudi Arabia, RiYADH, Saudi Arabia, 4Rheumatology Unit, Department of Paediatrics and Adolescent Medicine, Charles University in Prague, Dlouha 534, Kladno, 27201, Czech Republic, 5University of Health Sciences, Umraniye Tranining and Research Hospital Division of Pediatric Rheumatology, Istanbul, Turkey, Istanbul, Turkey, 6University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, 7Saint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russia, Sto arrivando!, Russia, 8Department of Pediatric Rheumatology and Immunology, University Hospital Muenster, Muenster, Germany, Muenster, Germany, 9Second Department of Paediatrics, P. & A. Kyriakou Children’s Hospital, Athens, Greece, Athens, Greece, 10Children's Hospital Zagreb, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, 11UOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy, Genoa, Italy, 12Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, Milan, Italy, 13Paediatric Rheumatology Unit, Anna Meyer Children's University Hospital, School of Human Health Science, Florence, Italy, Florence, Italy, 14University of Toronto, The Hospital for Sick Children, Toronto, Canada, 15Paediatric Rheumatology and Autoinflammatory Diseases Unit, General University Hospital, Prague, Czech Republic, Prague, Czech Republic, 16University of Health Sciences, Umraniye Tranining and Research Hospital Division of Pediatric Rheumatology Istanbul, Turkey, Istanbul, Turkey, 17Division of Rheumatology, Laboratory of Immuno-Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy

    Background/Purpose: Macrophage Activation Syndrome (MAS) is a severe, life-threatening, complication of Systemic Juvenile Idiopathic Arthritis (sJIA) with a significant mortality. A score that identify sJIA…
  • Abstract Number: 1174 • ACR Convergence 2020

    HEADSS and Shoulders, Knees and Toes: Improving Sexual Orientation and Gender Identity Screening in the Pediatric Rheumatology Clinic

    Nayimisha Balmuri1, Jacob Spitznagle1, Alexa Adams1, Karen Onel2, Sarah Taber1 and Nancy Pan1, 1Hospital for Special Surgery, new york, NY, 2Pediatric Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Adolescence is an especially vulnerable time when many rheumatologic conditions first present for diagnosis and management. Adolescence brings unique challenges including those relating to…
  • Abstract Number: 1187 • ACR Convergence 2020

    Red Cell Distribution Width Is Associated with ASCVD Risk Score and CVD in RA After Initiation of Methotrexate

    Ibtissam Gad1, Sofi Damjanovska2, Lenche Kostadinova3, Alyssa Lange4, Christopher Burant4, Brigid Wilson5, Taissa Bej5, Nora Singer6, Maya Mattar7, David Zidar8 and Donald Anthony9, 1Case Western Reserve/ Cleveland VA Medical Center, Cleveland Heights, OH, 2Case Western Reserve University/Cleveland VA Medical Center, Cleveland Heights, OH, 3(1) Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Highland Heights, OH, 4Case Western Reserve University, Cleveland, 5Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, 6The MetroHealth System, Case Western Reserve University School of Medicine, Cleveland, OH, 7Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, OH, 8Case Western Reserve University/Cleveland VA Medical Center, Cleveland, 9Case Western Reserve University/Cleveland VA Medical Center/MetroHealth Medical Center, Cleveland, OH

    Background/Purpose: Rheumatoid arthritis (RA) has been shown to be associated with increased risk of cardiovascular disease (CVD)  and mortality. Red cell distribution width (RDW) represents…
  • Abstract Number: 1193 • ACR Convergence 2020

    Unsupervised Molecular Profile Clustering in the Serum of Rheumatoid Arthritis Patients Identifies Groups with Differential CV-risk SCORE: Modulation by Biological Therapies

    Maria Luque-Tevar1, Carlos Pérez-Sánchez1, Pilar Font2, Alejandra Maria Patiño-Trives1, Montserrat Romero-Gomez2, Desirée Ruiz-Vilchez2, Sara Remuzgo-Martínez3, Raquel López-Mejías4, Iván Arias de la Rosa1, Carmen Torres-Granados1, María-Carmen Abalos-Aguilera1, Rafaela Ortega-Castro2, Alejandro Escudero-Contreras2, Carlos Rodriguez-Escalera5, Jose Perez-Venegas6, Mª Dolores Ruiz-Montesinos6, Carmen Dominguez6, Carmen Romero-Barco7, Antonio Fernandez-Nebro8, Natalia Mena-Vazquez9, Jose Luis Marenco10, Julia Uceda-Montañez10, Mª Dolores Toledo-Coello11, Nuria Barbarroja1, M Angeles Aguirre2, Eduardo Collantes2, Miguel A Gonzalez-Gay12 and Chary Lopez-Pedrera1, 1Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Cordoba, Spain, 2Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Córdoba, Spain, 3Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic bone diseases of the musculoskeletal system, IDIVAL, Santander, Spain, 4Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic bone Diseases of the Musculoskeletal System, IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 5Hospital Universitario de Jaen, Jaén, Spain, 6Hospital Universitario Virgen Macarena, Sevilla, Sevilla, Spain, 7Hospital Clínico Universitario, Málaga, Málaga, Spain, 8University of Malaga, Malaga, Spain, 9Hospital Regional Universitario de Málaga, Málaga, Spain, 10Hospital Universitario Virgen de Valme, Sevilla, Sevilla, Spain, 11Hospital Universitario de Jerez de la Frontera, Cádiz, Spain, Cádiz, Spain, 12Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander

    Background/Purpose: To identify specific molecular profiles associated to the enhanced cardiovascular (CV)-risk present in Rheumatoid Arthritis (RA) patients and their modulation by biologic disease modifying…
  • Abstract Number: 1286 • ACR Convergence 2020

    Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus by Physician Global Assessment of Disease Activity

    May Choi1, Emma Stevens2, Hongshu Guan2, Daniel Li3, Jack Ellrodt4, Benjamin Kargere4, Tianrun Cai2, Kazuki Yoshida5, Brendan Everett2 and Karen Costenbader6, 1Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Brigham and Women's Hospital, Boston, MA, 3Harvard, Columbus, OH, 4Williams College, Williamstown, 5Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: The risk of cardiovascular disease (CVD), including myocardial infarction and stroke, is higher in SLE than in the general population. The excess risk of…
  • Abstract Number: 045 • 2020 Pediatric Rheumatology Symposium

    No-Shows: a Search for Modifiable Risk Factors

    Samantha Ong 1, Xujia Li 1 and Austin Dalrymple2, 1Saint Louis University School of Medicine, St. Louis, 2Saint Louis University School of Medicine, Saint Louis, Missouri

    Background/Purpose: Missed ambulatory visits, or “no-shows,” limit patient access, increase costs, occupy provider time, and lead to worse patient outcomes. Only a few studies have…
  • Abstract Number: 2539 • 2019 ACR/ARP Annual Meeting

    Patient Perception of Benefit and Risks Associated with Hydroxychloroquine Use in Systemic Lupus Erythematosus (SLE)

    Sooyeon Kwon1, Jessica Farrell 2, Sarfaraz Hasni 3 and Shubhasree Banerjee 2, 1The Center For Rheumatology, Loudonville, NY, 2The Center for Rheumatology, LLC, Albany, NY, 3NIAMS, National Institutes of Health, Bethesda, MD

    Background/Purpose: Hydroxychloroquine (HCQ) is recommended in all patients with systemic lupus erythematosus (SLE).  Studies suggest that a significant proportion of subjects are non-adherent to daily…
  • Abstract Number: 1758 • 2019 ACR/ARP Annual Meeting

    Development of Ultrasound Detectable Arthritis Among ACPA Positive Subjects with Musculoskeletal Symptoms: The Risk RA Prospective Study

    Aase Hensvold1, Yogan Kisten 2, Alexandra Circiumaru 1, Monika Hansson 3, Meng Sun 1, Guozhong Fei 4, Nancy Vivar 2, Erik af Klint 2, Hamed Rezaei 2, Lars Klareskog 3, Aleksandra Antovic 5 and Anca Catrina 3, 1Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, 2Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 3Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 4Center for Rheumatology, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden, Stockholm, Sweden, 5Center for Rheumatology, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden

    Background/Purpose: Studies have shown that anti-citrullinated protein antibodies (ACPA) are a risk factor for the development of arthritis. We aimed to investigate in a prospective…
  • Abstract Number: 1960 • 2019 ACR/ARP Annual Meeting

    Pleiotropy of Genetic Predisposition to Rheumatoid Arthritis Increases the Risk for Autoimmune Disease

    Vivian Kawai1, Mingjian Shi 1, Qiping Feng 2, Cecilia Chung 1, Ge Liu 2, Nancy Cox 2, Dan Roden 2, C. Michael Stein 1 and Jonathan Mosley 2, 1Vanderbilt University Medical Center, Nashville, TN, 2Vanderbilt University Medical Center, Nashville

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disorder that is associated with increased risk of cardiovascular disease, cardiometabolic disorders, and autoimmune disease. Thus, we…
  • Abstract Number: 2136 • 2019 ACR/ARP Annual Meeting

    Cardiovascular Risk Evaluation in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Results from the “Cardiovascular Obesity and Rheumatic DISease (CORDIS)” Study Group of the Italian Society of Rheumatology

    Fabio Cacciapaglia1, Gian Luca Erre 2, Garifallia Sakellariou 3, Ombretta Viapiana 4, Matteo Piga 5, Elena Bartoloni 6, Andreina Manfredi 7, Sergio Colella 1, Floriana Castagna 2, Giacomo Cafaro 8, Martina Dessì 5, Marco Fornaro 1, Alessandro Giollo 9, Silvia Grignaschi 10, Caterina Vacchi 11, Francesca Romana Spinelli 12, Fabiola Atzeni 13 and Elisa Gremese 14, 1Rheumatology Unit – Department of Emergency and Organs Transplantation, University and AOU Policlinico of Bari, Italy, Bari, Italy, 2Specialità Mediche, Azienda Ospedaliero Universitaria di Sassari, Italy., Sassari, Italy, 3Division of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, 4University of Verona, Verona, Italy, 5Rheumatology Unit, Department of Medical Sciences, University and AOU Policlinico of Cagliari, Italy., Cagliari, Italy, 6Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy, Perugia, Italy, 7Rheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Emilia-Romagna, Italy, 8Rheumatology Unit, Department of Medicine, University of Perugia, Italy., Perugia, Italy, 9Rheumatology Unit, Department of Medicine, University of Verona, Italy., Verona, Italy, 10Division of Rheumatology, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy., Pavia, Italy, 11Rheumatology Unit, Department of Medical and Surgical Science, University and AOU Policlinico of Modena, Italy., Modena, 12Rheumatology, Department of Internal Medicine and Medical Speciality, Sapienza University of Rome, Italy., Rome, Italy, 13Rheumatology Unit, University of Messina, Messina, Italy., Messina, Italy, 14Fondazione Policlinico Gemelli-Università Cattolica del Sacro Cuore, Rome, Italy

    Background/Purpose: Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients present high cardiovascular (CV) morbidity and mortality. International guidelines suggest estimating CV-risk in these patients,…
  • Abstract Number: 2322 • 2019 ACR/ARP Annual Meeting

    Toward Cardiovascular Risk Stratification in Rheumatoid Arthritis: Use of Regression Tree Analyses to Evaluate Impact of Serum Biomarkers and Cardiovascular Risk Factors on Carotid Intima Media Thickness

    Kimberly Liang1, Yaming Li 1, Suresh Mulukutla 1, Steven Reis 1, Marc Levesque 1, Donald Jones 1, Rachel Gartland 1, Jennifer Avolio 1, Ali Hakim Shoushtari 1, Flordeliza Villanueva 1, Larry Moreland 1 and Douglas Landsittel 2, 1University of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, RI

    Background/Purpose: Both traditional cardiovascular (CV) risk factors and disease-related factors contribute to the increased risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA). Mechanisms of…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology